These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17456616)

  • 1. Post-transplant lymphoproliferative disorder--the potential of proliferation signal inhibitors.
    Pascual J
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i27-35. PubMed ID: 17456616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors.
    Campistol JM; Schena FP
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i17-22. PubMed ID: 17456614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation.
    de Fijter JW
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i23-6. PubMed ID: 17456615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance.
    Campistol JM; Albanell J; Arns W; Boletis I; Dantal J; de Fijter JW; Mortensen SA; Neumayer HH; Øyen O; Pascual J; Pohanka E; Schena FP; Serón D; Sparacino V; Chapman JR
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i36-41. PubMed ID: 17456617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus-induced remission of posttransplantation lymphoproliferative disorder.
    Cullis B; D'Souza R; McCullagh P; Harries S; Nicholls A; Lee R; Bingham C
    Am J Kidney Dis; 2006 May; 47(5):e67-72. PubMed ID: 16632009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everolimus in clinical practice--renal transplantation.
    Pascual J
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii18-23. PubMed ID: 16815852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients.
    Andrés V; Castro C; Campistol JM
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii14-7. PubMed ID: 16815851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical recommendations for the use of everolimus in heart transplantation.
    Manito N; Delgado JF; Crespo-Leiro MG; González-Vílchez F; Almenar L; Arizón JM; Díaz B; Fernández-Yáñez J; Mirabet S; Palomo J; Rodríguez Lambert JL; Roig E; Segovia J
    Transplant Rev (Orlando); 2010 Jul; 24(3):129-42. PubMed ID: 20619801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
    Valantine H
    J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients.
    Libertiny G; Watson CJ; Gray DW; Welsh KI; Morris PJ
    Br J Surg; 2001 Oct; 88(10):1330-4. PubMed ID: 11578286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of proliferation signal inhibitors in post-transplant malignancies.
    Gutiérrez-Dalmau A; Campistol JM
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i11-6. PubMed ID: 17360768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mTOR by sirolimus induces remission of post-transplant lymphoproliferative disorders.
    Boratyńska M; Smolska D
    Transpl Int; 2008 Jun; 21(6):605-8. PubMed ID: 18282244
    [No Abstract]   [Full Text] [Related]  

  • 14. Late conversion to mammalian target of rapamycin inhibitor/proliferation signal inhibitors in kidney transplant patients: clinical experience in the last 5 years.
    Sola E; Lopez V; Gutierrez C; Cabello M; Burgos D; Molina MG; Hernandez D
    Transplant Proc; 2010 Oct; 42(8):2859-60. PubMed ID: 20970551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses.
    Majewski M; Korecka M; Joergensen J; Fields L; Kossev P; Schuler W; Shaw L; Wasik MA
    Transplantation; 2003 May; 75(10):1710-7. PubMed ID: 12777861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab in association with rapamycin for post-transplant lymphoproliferative disease treatment.
    Garcia VD; Bonamigo Filho JL; Neumann J; Fogliatto L; Geiger AM; Garcia CD; Barros V; Keitel E; Bittar AE; Ferrera des Santos A; Roithmann S
    Transpl Int; 2003 Mar; 16(3):202-6. PubMed ID: 12664217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma.
    Jiménez-Rivera C; Avitzur Y; Fecteau AH; Jones N; Grant D; Ng VL
    Pediatr Transplant; 2004 Jun; 8(3):243-8. PubMed ID: 15176961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion to a proliferation signal inhibitor in a patient with coronary artery disease--a case report.
    Sparacino V; Calabrese S
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii34-7. PubMed ID: 16815856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphoproliferative disorders after renal transplantation in a child].
    Márquez U S; Peredo G MS; Vogel S A; Ibáñez A P
    Rev Med Chil; 2009 Mar; 137(3):405-10. PubMed ID: 19621184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival after post-transplant lymphoproliferative disease in children.
    Nathanson S; Debray D; Delarue A; Deschênes G
    Pediatr Nephrol; 2002 Aug; 17(8):668-72. PubMed ID: 12185479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.